[go: up one dir, main page]

MY196902A - Fixed dose pharmaceutical composition comprising mometasone and azelastine - Google Patents

Fixed dose pharmaceutical composition comprising mometasone and azelastine

Info

Publication number
MY196902A
MY196902A MYPI2015701670A MYPI2015701670A MY196902A MY 196902 A MY196902 A MY 196902A MY PI2015701670 A MYPI2015701670 A MY PI2015701670A MY PI2015701670 A MYPI2015701670 A MY PI2015701670A MY 196902 A MY196902 A MY 196902A
Authority
MY
Malaysia
Prior art keywords
azelastine
mometasone
pharmaceutical composition
fixed dose
dose pharmaceutical
Prior art date
Application number
MYPI2015701670A
Inventor
Ulhas Dhuppad
Sunil Chaudhari
Suresh Rajurkar
Piyush Agarwal
Original Assignee
Glenmark Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from BR102013000830A external-priority patent/BR102013000830A2/en
Application filed by Glenmark Pharmaceuticals Ltd filed Critical Glenmark Pharmaceuticals Ltd
Publication of MY196902A publication Critical patent/MY196902A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention relates to a fixed dose pharmaceutical composition comprising mometasone and azelastine. Particularly, the present invention provides a stable fixed dose pharmaceutical composition in the form of a nasal spray comprising mometasone or its salt and azelastine or its salt; a process for preparing such composition; and its use in treatment of rhinitis in a subject.
MYPI2015701670A 2012-12-06 2013-12-04 Fixed dose pharmaceutical composition comprising mometasone and azelastine MY196902A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN3454MU2012 2012-12-06
BR102013000830A BR102013000830A2 (en) 2013-01-11 2013-01-11 PHARMACEUTICAL COMPOSITION FOR NASAL ADMINISTRATION, AND, USE OF THE SAME
PCT/IB2013/060638 WO2014087347A1 (en) 2012-12-06 2013-12-04 Fixed dose pharmaceutical composition comprising mometasone and azelastine

Publications (1)

Publication Number Publication Date
MY196902A true MY196902A (en) 2023-05-09

Family

ID=50882873

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2015701670A MY196902A (en) 2012-12-06 2013-12-04 Fixed dose pharmaceutical composition comprising mometasone and azelastine

Country Status (7)

Country Link
EP (1) EP2928302A1 (en)
EA (1) EA037259B1 (en)
MX (2) MX390789B (en)
MY (1) MY196902A (en)
PH (1) PH12015501179A1 (en)
WO (1) WO2014087347A1 (en)
ZA (1) ZA201503799B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109288790A (en) * 2017-07-25 2019-02-01 健乔信元医药生技股份有限公司 Nasal pharmaceutical composition and preparation method thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2389530B (en) * 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
US20070020330A1 (en) * 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof

Also Published As

Publication number Publication date
EP2928302A1 (en) 2015-10-14
PH12015501179A1 (en) 2015-08-17
ZA201503799B (en) 2016-02-24
MX2019001701A (en) 2019-08-14
EA201491769A1 (en) 2015-06-30
MX2014003546A (en) 2014-12-09
EA037259B1 (en) 2021-03-01
MX390789B (en) 2025-03-21
WO2014087347A1 (en) 2014-06-12

Similar Documents

Publication Publication Date Title
PH12016500433B1 (en) Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine
TN2015000278A1 (en) Autotaxin inhibitors
PH12015502615B1 (en) Chemical compounds
PH12015500274B1 (en) Alkylpyrimidine derivatives for the treatment of viral infections and further diseases
PH12014501738A1 (en) Piperidino-pyrimidine derivatives for the treatment of viral infections
PH12015500983A1 (en) Heterocyclic substituted 2-amino-quinazoline derivatives for the treatment of viral infections
MX2015016983A (en) Nuclear transport modulators and uses thereof.
PH12015500115A1 (en) Glucagon analogues
IN2014DN10670A (en)
NZ702663A (en) Nuclear transport modulators and uses thereof
MX2014009757A (en) Isoindoline derivatives, pharmaceutical compositions containing them, and their use in therapy.
MX366899B (en) New compounds.
MX349004B (en) New compounds.
PH12015500713A1 (en) Acylaminopyrimidine derivatives for the treatment of viral infections and further diseases
MX2015004362A (en) Ketamine derivatives.
MX362879B (en) Novel uses.
MX2016004934A (en) Aminotetraline and aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy.
MX2015008454A (en) Use of pregn-4-en-20-yn-3-one for the treatment of depressive disorders.
UA115307C2 (en) APPLICATION OF MEDICINAL PRODUCT CONTAINING RECOMBINANT LECTIN MELINES FOR TREATMENT OF SKIN CANCER
GB201115977D0 (en) Neurodevelopmental disorders
PH12015501179A1 (en) Fixed dose pharmaceutical composition comprising mometasone and azelastine
IN2014DN10683A (en)
MX2013002446A (en) Substituted tetrahydropyrrolopyrazine derivatives.